Jason Kelly
Fortune : 22 M $ au 31/05/2026
Fortune : 22 M $ au 31/05/2026
Jason Kelly a fondé Ginkgo Bioworks Holdings, Inc. et Ginkgo Bioworks, Inc. Il occupe actuellement le poste de directeur général et de directeur de Ginkgo Bioworks Holdings, Inc. et de directeur général et de directeur de Ginkgo Bioworks, Inc. (une filiale de Ginkgo Bioworks Holdings, Inc.). Le Dr Kelly est également membre du conseil d'administration d'Octant, Inc. et de Motif Food Works, Inc. Dans sa carrière antérieure, le Dr Kelly a été directeur général et administrateur de Soaring Eagle Acquisition Corp. Il a obtenu un diplôme de premier cycle et un doctorat au Massachusetts Institute of Technology.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 15/04/2026 | 2 041 437 ( 22,21% ) | 19 M $ | 31/05/2026 | |
| 15/04/2026 | 316 483 ( 0,59% ) | 3 M $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| GINKGO BIOWORKS HOLDINGS, INC. | Fondateur | 01/01/2008 |
Ginkgo Bioworks, Inc.
Ginkgo Bioworks, Inc. Information Technology ServicesTechnology Services Develops biological technology and software solutions | Fondateur | 01/01/2008 |
Motif Food Works, Inc.
Motif Food Works, Inc. Food: Major DiversifiedConsumer Non-Durables Operates as a food ingredients company which provides sustainable alternative proteins and ingredient solutions | Directeur/Membre du Conseil | - |
Octant, Inc.
Octant, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Directeur/Membre du Conseil | - |
Gen9, Inc.
Gen9, Inc. BiotechnologyHealth Technology Develops synthetic biology technologies | Directeur/Membre du Conseil | - |
NextGen Venture Partners LLC
NextGen Venture Partners LLC Investment ManagersFinance NextGen Venture Partners invests in companies located in the United States with a minimum revenues of USD 10 million. The firm focuses on a broad range of sectors and industries. It provides financing for seed, early and growth stage capital requirements with an investment size of USD 0.5 - 2 million for seed and early stage companies and USD 3 - 5 million for growth stage companies. | Private Equity Investor | - |
| Sociétés | Poste | Fin |
|---|---|---|
| STANDARD BIOTOOLS INC. | Directeur/Membre du Conseil | 01/09/2021 |
| GINO BIOW | Directeur Général | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 9 |
|---|---|
Gen9, Inc.
Gen9, Inc. BiotechnologyHealth Technology Develops synthetic biology technologies | Health Technology |
Octant, Inc.
Octant, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Commercial Services |
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Ginkgo Bioworks, Inc.
Ginkgo Bioworks, Inc. Information Technology ServicesTechnology Services Develops biological technology and software solutions | Technology Services |
NextGen Venture Partners LLC
NextGen Venture Partners LLC Investment ManagersFinance NextGen Venture Partners invests in companies located in the United States with a minimum revenues of USD 10 million. The firm focuses on a broad range of sectors and industries. It provides financing for seed, early and growth stage capital requirements with an investment size of USD 0.5 - 2 million for seed and early stage companies and USD 3 - 5 million for growth stage companies. | Finance |
Motif Food Works, Inc.
Motif Food Works, Inc. Food: Major DiversifiedConsumer Non-Durables Operates as a food ingredients company which provides sustainable alternative proteins and ingredient solutions | Consumer Non-Durables |
CM Life Sciences II, Inc.
CM Life Sciences II, Inc. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Soaring Eagle Acquisition Corp.
Soaring Eagle Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Ginkgo Bioworks Holdings, Inc.
Ginkgo Bioworks Holdings, Inc. Medical/Nursing ServicesHealth Services Develops biological engineering products and custom microbes | Health Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national